Baker Bros. Advisors »

Evommune shares owned by Baker Bros. Advisors

Quarter-by-quarter ownership of Evommune (EVMN) shares owned by Baker Bros. Advisors from 13F filings

Historical chart of Baker Bros. Advisors investment in Evommune

Tip: Access up to 7 years of quarterly data

All positions including Evommune held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Evommune by Baker Bros. Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $20M 847k 22.99

More positions owned by Baker Bros. Advisors

Incyte Corporation (INCY)
BeOne Medicines Sponsored Ads (ONC)
Insmed Incorporated Com Par $.01 (INSM)
Madrigal Pharmaceuticals (MDGL)
ACADIA Pharmaceuticals (ACAD)
Revolution Medicines (RVMD)
Celcuity (CELC)
Kodiak Sciences (KOD)
Kymera Therapeutics (KYMR)
Summit Therapeutics (SMMT)
Praxis Precision Medicines I (PRAX)
Rhythm Pharmaceuticals (RYTM)
Alkermes SHS (ALKS)
Grail (GRAL)
Edgewise Therapeutics (EWTX)

View all positions for Baker Bros. Advisors

Top funds holding Evommune

EQT Fund Management S.a r.l.
RA Capital Management
Pivotal bioVenture Partners Investment Advisor
Andera Partners
MPM Oncology Impact Management
Nan Fung Group Holdings
Rtw Investments
SymBiosis Capital Partners
Marshall Wace
Eventide Asset Management
Henderson Group
Baker Bros. Advisors
Alyeska Investment Group
BlackRock
Kynam Capital Management

View all funds holding Evommune